Brain and nervous system

Nerve Conduction Studies and EMG: What They Actually Measure

Nerve conduction studies measure how fast and how strongly electrical signals travel along a nerve, while EMG records the electrical behavior of muscle. Together they detect where a nerve is injured and how, but they measure nerve physiology, not symptoms, so a normal result does not always rule out disease.

What do these tests actually measure?

Nerve conduction studies measure how fast and how strongly an electrical signal travels along a nerve, while electromyography, or EMG, records the electrical behavior of a muscle at rest and during contraction. Together they describe the physiology of your nerves and muscles: where a signal slows down, where it weakens, and whether a muscle has lost its nerve supply. They measure the wiring, not the sensation. That distinction explains most of what these tests can and cannot tell you.

Put plainly, an electrodiagnostic study is a functional map of your peripheral nervous system. It confirms whether a nerve is injured, roughly where along its path, and by what mechanism, but it does not measure pain, numbness, or how much a problem bothers you. Those live in your report of symptoms, which is why the test supports a diagnosis rather than replacing the clinical picture.

Nerve conduction studies: speed and signal size

In a nerve conduction study, small surface electrodes deliver a brief, mild electrical pulse over a nerve and record the response farther along. The machine captures two things that matter most: latency, meaning how long the signal takes to arrive, and amplitude, meaning how large the recorded response is. A delayed latency points toward demyelination, damage to the insulating sheath that lets signals travel quickly. A reduced amplitude points toward axon loss, damage to the nerve fibers themselves.

Carpal tunnel syndrome is the textbook example. When the median nerve is compressed at the wrist, its signal slows across that short segment before anything else changes, so a prolonged sensory or motor latency across the wrist is the earliest reliable finding. A 2015 review in Advanced Biomedical Research, drawing on established practice parameters, reports that delayed sensory latencies appear in roughly 49 to 66 percent of patients with the syndrome, and delayed motor latencies in about 60 to 74 percent, while specificity across these measures runs from roughly 95 to 100 percent. Comparison techniques, which pit the median nerve against a neighboring ulnar or radial nerve in the same hand, push sensitivity higher still.

EMG: listening to muscle

Needle EMG is the second half of the study. A thin needle electrode is placed into selected muscles, and the examiner listens, on screen and through audio, to the electrical activity. A healthy muscle at rest is electrically silent. Spontaneous activity such as fibrillation potentials and positive sharp waves signals that muscle fibers have lost their nerve supply, a state called denervation. During gentle contraction, the shape and recruitment of motor unit potentials reveal whether damage is recent or old, and whether the muscle has been reinnervating.

Timing is a real constraint here. Fibrillations rarely appear before about two weeks after a nerve injury and may take four to six weeks to develop fully, so an EMG done too early can look reassuringly normal while a genuine injury is still declaring itself. This is one reason clinicians often wait several weeks after symptom onset before ordering the study.

Confirming carpal tunnel, and its honest limits

Electrodiagnostic testing is a valid and reliable way to confirm median nerve compression at the wrist, and it helps grade severity and exclude mimics such as a more diffuse neuropathy. But a 2018 expert discussion in Clinical Neurophysiology Practice makes an important point often lost on patients: the test documents median neuropathy at the wrist, an objective physiological finding, which is not quite the same thing as the clinical syndrome a person experiences. The two usually align, but not always.

That gap runs in both directions. Some people with clear symptoms have normal studies, because early or purely intermittent compression can leave conduction measurably intact. And abnormal conduction can appear in people without complaints; the same source notes that a meaningful fraction of the general population, by some estimates up to a fifth, can show median slowing at the wrist without symptoms. The correlation between how abnormal the numbers look and how severe a person feels is modest at best.

Sensitivity, specificity, and why they trade off

Two numbers govern how much weight a result deserves. Sensitivity is the share of truly affected people the test catches; specificity is the share of unaffected people it correctly clears. Electrodiagnostic tests for carpal tunnel are built to favor specificity, often above 95 percent, which is deliberate. A test used to confirm a diagnosis should rarely flag healthy nerves, even at the cost of missing some mild cases.

The trade-off is unavoidable. Loosening the threshold to catch more early cases raises sensitivity but lets in more false positives; tightening it does the reverse. The 2018 discussion illustrates this directly, citing criteria that yield roughly 69 percent sensitivity with 97 percent specificity, versus others reaching 92 percent sensitivity but only 63 percent specificity. There is no single cutoff that is simply correct; there is only the one matched to the question being asked.

Beyond the wrist

The same principles extend to other conditions. In suspected radiculopathy, a pinched nerve root in the spine, needle EMG shows modest sensitivity, estimated by an AANEM practice parameter at roughly 50 to 71 percent for cervical roots, paired with very high specificity. It can confirm and localize active nerve-root injury but cannot pinpoint the exact spinal level with precision, because the muscles it samples draw innervation from overlapping roots. For generalized polyneuropathies, the studies map the pattern, whether damage is mainly to axons or myelin, sensory or motor, symmetric or patchy, which narrows a long list of possible causes.

The practical takeaway is consistent across all of these uses. An electrodiagnostic study is strong confirmation when it is positive and the clinical suspicion is high, and it is a weaker rule-out when it is negative, because the physiology it measures can lag behind, or run ahead of, what a person feels. Read alongside the history and examination, it is one of the most objective tools in neurology. Read alone, it is a map missing its legend. This article is educational and not a substitute for individual medical advice.

References and sources

  1. Practical Approach to Electrodiagnosis of Carpal Tunnel Syndrome (Advanced Biomedical Research, 2015)
  2. Nerve Conduction Studies and EMG in Carpal Tunnel Syndrome: Do They Add Value? (Clinical Neurophysiology Practice, 2018)
  3. Practice Parameter for Electrodiagnostic Studies in Carpal Tunnel Syndrome (AANEM/AAN/AAPMR)
  4. Practice Parameter for Needle EMG Evaluation of Patients with Suspected Cervical Radiculopathy (AANEM)

How this was researched. This explainer is built from the primary sources listed above and reflects Dr. Tojjar's own critical appraisal of that evidence. It explains and evaluates research and does not provide medical care.

This article is for general education and is not medical or professional advice. For guidance about your own health, talk with a qualified clinician.

Cite this article

Tojjar, D. (2025). Nerve Conduction Studies and EMG: What They Actually Measure. Dr. Damon Tojjar. https://readingtheevidence.org/articles/nerve-conduction-studies-and-emg-what-they-measure/

Back to all insights